2022-01-13Zeitschriftenartikel
Cost-savings and potential cost-savings through the distribution of generic antiretroviral drugs within the statutory health insurance market of Germany between January 2017 and June 2019
Lottes, Matthäus; Bremer, Viviane; Prugger, Christof; Christian, Kollan; Schmidt, Daniel
Background: Recent patent losses for antiretroviral drugs (ARV) have led to the debate of cost-saving
through the replacement of patented drugs with generic drugs. The split of recommended single-tablet regimens
(STR) ...
